Latest Insider Transactions at Alimera Sciences Inc (ALIM)
This section provides a real-time view of insider transactions for Alimera Sciences Inc (ALIM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALIMERA SCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALIMERA SCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2021
|
John Philip Jones Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
421
+2.11%
|
$1,263
$3.56 P/Share
|
|
Apr 30
2021
|
Richard S Eiswirth Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
500
+0.83%
|
$1,500
$3.56 P/Share
|
|
Apr 30
2021
|
David Holland Chief Marketing Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
500
+1.91%
|
$1,500
$3.56 P/Share
|
|
Apr 08
2021
|
Philip Ashman President of Int'l Operations |
SELL
Open market or private sale
|
Direct |
45
-0.23%
|
$405
$9.62 P/Share
|
|
Mar 09
2021
|
John Philip Jones Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,164
-5.73%
|
$8,148
$7.64 P/Share
|
|
Mar 08
2021
|
David Holland Chief Marketing Officer & SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,935
-7.15%
|
$13,545
$7.42 P/Share
|
|
Mar 04
2021
|
Philip Ashman President of Int'l Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,533
-11.54%
|
$17,731
$7.77 P/Share
|
|
Jan 07
2021
|
David Holland Chief Marketing Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+17.21%
|
-
|
|
Jan 07
2021
|
Samer Kaba Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+29.51%
|
-
|
|
Jan 07
2021
|
Philip Ashman President of Int'l Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+31.29%
|
-
|
|
Jan 07
2021
|
John Philip Jones Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,625
+23.83%
|
-
|
|
Jan 07
2021
|
Richard S Eiswirth Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+22.71%
|
-
|
|
Nov 04
2020
|
Philip Ashman President of Int'l Operations |
BUY
Open market or private purchase
|
Direct |
1,316
+9.91%
|
$5,264
$4.5 P/Share
|
|
Nov 02
2020
|
Richard S Eiswirth Jr President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+5.61%
|
$10,000
$4.15 P/Share
|
|
Oct 30
2020
|
Richard S Eiswirth Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
500
+1.25%
|
$1,500
$3.56 P/Share
|
|
Oct 30
2020
|
David Holland Chief Marketing Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
500
+2.28%
|
$1,500
$3.56 P/Share
|
|
Oct 30
2020
|
John Philip Jones Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
421
+3.3%
|
$1,263
$3.56 P/Share
|
|
Feb 06
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 06
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.12%
|
$8,000
$1.12 P/Share
|
|
Feb 05
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 05
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000
+0.06%
|
$4,000
$1.14 P/Share
|
|
Feb 02
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 02
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.12%
|
$8,000
$1.16 P/Share
|